Memorial Sloan-Kettering Cancer Center
Interviews and expert commentary tagged “Memorial Sloan-Kettering Cancer Center” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Audio Journal of Oncology
Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma
Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma An interview with: Mark A Dickson MD, Medical Oncologist, Associate Attending Ph
15 June 2026
7:24

Audio Journal of Oncology
Clear-cell renal cell cancer: first molecular prognostic marker also brings scope for drug targeting
SAN FRANCISCO— A recently discovered molecular prognostic biomarker for clear-cell renal cell cancer has been validated and shown to indicate a four-fold increase in risk of adverse cancer-specific su
27 February 2014
0:00